Barinthus Biotherapeutics Operating Income History
| BRNS Stock | 0.60 -0.01 -1.66% |
Operating Income | First Reported 2020-03-31 | Previous Quarter -15.1 M | Current Value 4.8 M | Quarterly Volatility 10.9 M |
Macro event markers
Latest Barinthus Biotherapeutics Operating Income Growth Pattern
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Operating Income Trend Statistics
Over 7 reporting periods, Barinthus Biotherapeutics' Operating Income shows a coefficient of variation of 58.1%, indicating elevated dispersion relative to the mean. An R-squared of 0.35 points to a moderate linear trend with partial explanatory power.| Arithmetic Mean | -34,643,361 | |
| Coefficient Of Variation | -58.11 | |
| Mean Deviation | 15,880,778 | |
| Median | -25,664,672 | |
| Standard Deviation | 20,130,331 | |
| Sample Variance | 405.2T | |
| Range | 79.9M | |
| R-Value | -0.59 | |
| Mean Square Error | 283T | |
| R-Squared | 0.35 | |
| Significance | 0.01 | |
| Slope | -2,342,251 | |
| Total Sum of Squares | 6483.7T |
Barinthus Biotherapeutics Operating Income History
From 2020 to 2026, Barinthus Biotherapeutics' Operating Income is reported across 7 periods, starting at -20 M and most recently at -56.9 M.Correlation of Operating Income With Other Accounts
Pairwise correlations for Barinthus Biotherapeutics' Operating Income are computed across overlapping reporting periods. These relationships are descriptive and may shift under different market conditions.Click cells to compare fundamentals
Related Fundamentals
| Last Reported | End Of Year Estimate | ||
| Other Operating Expenses | 54.2 M | 58.7 M | |
| Total Operating Expenses | 48.3 M | 50.8 M | |
| Non Operating Income Net Other | -2.9 M | -3.1 M | |
| Total Cash From Operating Activities | -48 M | -45.6 M | |
| Change To Operating Activities | -3.7 M | -3.5 M | |
| Cash Flows Other Operating | -6.7 M | -7.1 M | |
| Operating Cash Flow Per Share | -1.18 | -1.24 | |
| EV To Operating Cash Flow | 0.64 | 0.67 | |
| Operating Cycle | 364.48 | 346.26 | |
| Price To Operating Cash Flows Ratio | -0.59 | -0.62 | |
| Operating Profit Margin | -522.00% | -548.00% | |
| Operating Cash Flow Sales Ratio | -2.22 | -2.33 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.00 | 0.87 |
Methodology, Assumptions & Data Sources
Period-over-period Operating Income data for Barinthus Biotherapeutics is shown below. The coefficient of variation quantifies dispersion relative to the mean across the full reporting history. For Barinthus Biotherapeutics as a Biotechnology company, Operating Income is driven by the competitive and demand dynamics of its end markets.
Reported values for Barinthus Biotherapeutics plc are derived from periodic company reporting and market reference feeds and standardized for analysis. Reference data and historical patterns are presented and do not constitute an investment recommendation or advice.
Editorial review and methodology oversight provided by: Raphi Shpitalnik, Junior Member of Macroaxis Editorial Board